Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Brenner

Showing results (211-220 of 224) with videos related to

Pageof 23
Sort By:
International Journal of Surgery (London, England)|July 8, 2024
Crystalloid volume versus catecholamines for management of hemorrhagic shock during esophagectomy: assessment of microcirculatory tissue oxygenation of the gastric conduit in a porcine model using hyperspectral imaging - an experimental studyAlexander Studier-Fischer, Berkin Özdemir, Maike Rees, et al.
Intensive Care Medicine|June 30, 2026
Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trialThorsten Brenner, Annabell Skarabis, Stefan J Schaller, et al.
Journal of Nephrology|July 2, 2022
Impact of low eGFR on the immune response against COVID-19Arturo Blazquez-Navarro, Lisa Mittmann, Constantin Joachim Thieme, et al.
Nature|July 28, 2022
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19Fotios Karagiannis, Konrad Peukert, Laura Surace, et al.
Medical Microbiology and Immunology|April 19, 2026
Acute COVID-19 is associated with altered CD8 T-cells indicative of impaired ability to control Epstein-Barr virus reactivationUlrik Stervbo, Moritz Anft, Krystallenia Paniskaki, et al.
The Journal of Infection|August 7, 2025
Improved pathogen identification in sepsis or septic shock by clinical metagenomic sequencingThorsten Brenner, Sebastian O Decker, Yevhen Vainshtein, et al.
Nature Communications|February 19, 2021
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsAlan Bénard, Anne Jacobsen, Maximilian Brunner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2020
COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a<sup>+</sup>Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez-Navarro, et al.
Journal of Critical Care|August 10, 2020
Therapy limitation in octogenarians in German intensive care units is associated with a longer length of stay and increased 30 days mortality: A prospective multicenter studyRaphael Romano Bruno, Bernhard Wernly, Michael Beil, et al.
Critical Care (London, England)|August 18, 2021
Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohortHarry Magunia, Simone Lederer, Raphael Verbuecheln, et al.
Pageof 23

Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
International Journal of Surgery (London, England)|July 8, 2024
Crystalloid volume versus catecholamines for management of hemorrhagic shock during esophagectomy: assessment of microcirculatory tissue oxygenation of the gastric conduit in a porcine model using hyperspectral imaging - an experimental studyAlexander Studier-Fischer, Berkin Özdemir, Maike Rees, et al.
Intensive Care Medicine|June 30, 2026
Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trialThorsten Brenner, Annabell Skarabis, Stefan J Schaller, et al.
Journal of Nephrology|July 2, 2022
Impact of low eGFR on the immune response against COVID-19Arturo Blazquez-Navarro, Lisa Mittmann, Constantin Joachim Thieme, et al.
Nature|July 28, 2022
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19Fotios Karagiannis, Konrad Peukert, Laura Surace, et al.
Medical Microbiology and Immunology|April 19, 2026
Acute COVID-19 is associated with altered CD8 T-cells indicative of impaired ability to control Epstein-Barr virus reactivationUlrik Stervbo, Moritz Anft, Krystallenia Paniskaki, et al.
The Journal of Infection|August 7, 2025
Improved pathogen identification in sepsis or septic shock by clinical metagenomic sequencingThorsten Brenner, Sebastian O Decker, Yevhen Vainshtein, et al.
Nature Communications|February 19, 2021
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsAlan Bénard, Anne Jacobsen, Maximilian Brunner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2020
COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a<sup>+</sup>Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez-Navarro, et al.
Journal of Critical Care|August 10, 2020
Therapy limitation in octogenarians in German intensive care units is associated with a longer length of stay and increased 30 days mortality: A prospective multicenter studyRaphael Romano Bruno, Bernhard Wernly, Michael Beil, et al.
Critical Care (London, England)|August 18, 2021
Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohortHarry Magunia, Simone Lederer, Raphael Verbuecheln, et al.
Pageof 23